Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-03

AUTHORS

Tsugio Ebihara, Shohei Koyama, Katashi Fukao, Toshiaki Osuga

ABSTRACT

T-cell-growth-factor (TCGF) activated peripheral blood lymphocytes (PBL), cultured for 14 days, showed killer cell activities against natural-killer resistant Daudi cells in a 4 h 51Cr-release assay. However, the effector cells obtained from patients with nonresectable carcinoma exhibited very much lower cytotoxicity to tumor cells. To analyze the mechanism of depression, we have attempted to examine suppressor cell activities of the TCGF-activated PBL. The assay for the suppressor cell activities was made by in vitro inhibition of cell-mediated cytotoxicity by incubating radiolabeled target tumor cells with lymphokine-activated killer (LAK) cells and TCGF-activated PBL. LAK cells were induced by cultivation with recombinant interleukin-2. TCGF-activated PBL, obtained from four out of ten patients with resectable carcinoma and nine out of ten patients with nonresectable carcinoma, significantly suppressed the LAK cell activities. However, this suppression was not observed in TCGF-activated PBL from ten normal healthy control subjects. TCGF-activated PBL with immunosuppressive reactivity were named lymphokine-activated suppressor (LAS) cells. To investigate the phenotypic characterization of TCGF-activated PBL, the cells were analyzed by two-color flow cytometry. TCGF preferentially expanded CD8+CD11− cells and decreased the growth of CD8+CD11+ cells in both normal healthy control subjects and gastric cancer (resectable and nonresectable) patients. Dominantly expressed CD8+CD11− cells on TCGF-activated PBL in patients — especially those with nonresectable gastric carcinoma — showed strong LAS cell activity, irrespective of the presence of killer cell activities of CD8+CD11− cells in TCGF-activated PBL from normal healthy control subjects. The results suggested the generation of CD8+CD11− LAS cells from cancer patients, and revealed that CD8+CD11− T-cells contained killer and/or suppressor cell function. In addition, it was found that the TCGF-activated PBL from gastric cancer patients were associated with an increased proportion of CD4+Leu8+, HLA-DR+CD8+ and HLA-DR+CD25+ cells. More... »

PAGES

218-224

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00204992

DOI

http://dx.doi.org/10.1007/bf00204992

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051413525

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2522349


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Separation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HLA-DR Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Regulatory", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ebihara", 
        "givenName": "Tsugio", 
        "id": "sg:person.01073271343.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073271343.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koyama", 
        "givenName": "Shohei", 
        "id": "sg:person.0657656236.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, 305, Tsukuba City, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, 305, Tsukuba City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukao", 
        "givenName": "Katashi", 
        "id": "sg:person.01234530531.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234530531.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Osuga", 
        "givenName": "Toshiaki", 
        "id": "sg:person.0661061456.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661061456.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/280685a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006685440", 
          "https://doi.org/10.1038/280685a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/311565a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015470890", 
          "https://doi.org/10.1038/311565a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02468883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038549596", 
          "https://doi.org/10.1007/bf02468883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00917143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003089650", 
          "https://doi.org/10.1007/bf00917143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/291335a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036146781", 
          "https://doi.org/10.1038/291335a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-03", 
    "datePublishedReg": "1989-03-01", 
    "description": "T-cell-growth-factor (TCGF) activated peripheral blood lymphocytes (PBL), cultured for 14 days, showed killer cell activities against natural-killer resistant Daudi cells in a 4 h 51Cr-release assay. However, the effector cells obtained from patients with nonresectable carcinoma exhibited very much lower cytotoxicity to tumor cells. To analyze the mechanism of depression, we have attempted to examine suppressor cell activities of the TCGF-activated PBL. The assay for the suppressor cell activities was made by in vitro inhibition of cell-mediated cytotoxicity by incubating radiolabeled target tumor cells with lymphokine-activated killer (LAK) cells and TCGF-activated PBL. LAK cells were induced by cultivation with recombinant interleukin-2. TCGF-activated PBL, obtained from four out of ten patients with resectable carcinoma and nine out of ten patients with nonresectable carcinoma, significantly suppressed the LAK cell activities. However, this suppression was not observed in TCGF-activated PBL from ten normal healthy control subjects. TCGF-activated PBL with immunosuppressive reactivity were named lymphokine-activated suppressor (LAS) cells. To investigate the phenotypic characterization of TCGF-activated PBL, the cells were analyzed by two-color flow cytometry. TCGF preferentially expanded CD8+CD11\u2212 cells and decreased the growth of CD8+CD11+ cells in both normal healthy control subjects and gastric cancer (resectable and nonresectable) patients. Dominantly expressed CD8+CD11\u2212 cells on TCGF-activated PBL in patients \u2014 especially those with nonresectable gastric carcinoma \u2014 showed strong LAS cell activity, irrespective of the presence of killer cell activities of CD8+CD11\u2212 cells in TCGF-activated PBL from normal healthy control subjects. The results suggested the generation of CD8+CD11\u2212 LAS cells from cancer patients, and revealed that CD8+CD11\u2212 T-cells contained killer and/or suppressor cell function. In addition, it was found that the TCGF-activated PBL from gastric cancer patients were associated with an increased proportion of CD4+Leu8+, HLA-DR+CD8+ and HLA-DR+CD25+ cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00204992", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "normal healthy control subjects", 
      "peripheral blood lymphocytes", 
      "healthy control subjects", 
      "killer cell activity", 
      "suppressor cell activity", 
      "gastric cancer patients", 
      "cancer patients", 
      "control subjects", 
      "cell activity", 
      "nonresectable carcinoma", 
      "suppressor cells", 
      "h 51Cr-release assay", 
      "lymphokine-activated killer cells", 
      "tumor cells", 
      "two-color flow cytometry", 
      "suppressor cell function", 
      "LAK cell activity", 
      "cell-mediated cytotoxicity", 
      "recombinant interleukin-2", 
      "mechanisms of depression", 
      "target tumor cells", 
      "resectable carcinoma", 
      "effector cells", 
      "killer cells", 
      "LAK cells", 
      "blood lymphocytes", 
      "interleukin-2", 
      "T cells", 
      "gastric carcinoma", 
      "resistant Daudi cells", 
      "patients", 
      "carcinoma", 
      "Daudi cells", 
      "flow cytometry", 
      "cell function", 
      "TCGF", 
      "HLA", 
      "subjects", 
      "cells", 
      "phenotypic characterization", 
      "cytotoxicity", 
      "assays", 
      "lymphocytes", 
      "activity", 
      "lymphokines", 
      "cytometry", 
      "depression", 
      "killer", 
      "low cytotoxicity", 
      "inhibition", 
      "days", 
      "suppression", 
      "proportion", 
      "factors", 
      "presence", 
      "mechanism", 
      "reactivity", 
      "function", 
      "addition", 
      "results", 
      "growth", 
      "characterization", 
      "generation", 
      "cultivation"
    ], 
    "name": "Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma", 
    "pagination": "218-224", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051413525"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00204992"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2522349"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00204992", 
      "https://app.dimensions.ai/details/publication/pub.1051413525"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_211.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00204992"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00204992'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00204992'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00204992'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00204992'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      112 URIs      98 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00204992 schema:about N0f6362dfda0e4b19add6c77345db2b28
2 N110aec6383e04355aa094f0f7f6feca6
3 N230effeb10c348c7984eacfd41feebeb
4 N3535a43dd6454d24b55ed3f540e3ad6a
5 N3fb54882631c4bd6959f764d6a3c0cad
6 N5541cc9268df4fe59039609e041fe37f
7 N569d59315dc246af9bd89440f32e77c0
8 N640cf1e41c414b709e2d81bec57c0613
9 N8138b1a7658047f98d25a1b311d4e553
10 Na586cc16230e4548addcc863b50f1b8f
11 Nc183850d52e840c1ad92b4e9165ea73c
12 Nc3117c25cec44365ad0da784855e10f5
13 Nce75938bc60a4c61ae5d7f06b342de40
14 Nd75c7c09b7e6452ea6d080fb1089c4d2
15 Nf9c6d361798d4d208d8a18687e2ce2e6
16 Nfbaf817644cf438b903bf5ecbbbe72e1
17 anzsrc-for:11
18 anzsrc-for:1107
19 anzsrc-for:1112
20 schema:author Nc08b12f2f94240c4b89702252c85b924
21 schema:citation sg:pub.10.1007/bf00917143
22 sg:pub.10.1007/bf02468883
23 sg:pub.10.1038/280685a0
24 sg:pub.10.1038/291335a0
25 sg:pub.10.1038/311565a0
26 schema:datePublished 1989-03
27 schema:datePublishedReg 1989-03-01
28 schema:description T-cell-growth-factor (TCGF) activated peripheral blood lymphocytes (PBL), cultured for 14 days, showed killer cell activities against natural-killer resistant Daudi cells in a 4 h 51Cr-release assay. However, the effector cells obtained from patients with nonresectable carcinoma exhibited very much lower cytotoxicity to tumor cells. To analyze the mechanism of depression, we have attempted to examine suppressor cell activities of the TCGF-activated PBL. The assay for the suppressor cell activities was made by in vitro inhibition of cell-mediated cytotoxicity by incubating radiolabeled target tumor cells with lymphokine-activated killer (LAK) cells and TCGF-activated PBL. LAK cells were induced by cultivation with recombinant interleukin-2. TCGF-activated PBL, obtained from four out of ten patients with resectable carcinoma and nine out of ten patients with nonresectable carcinoma, significantly suppressed the LAK cell activities. However, this suppression was not observed in TCGF-activated PBL from ten normal healthy control subjects. TCGF-activated PBL with immunosuppressive reactivity were named lymphokine-activated suppressor (LAS) cells. To investigate the phenotypic characterization of TCGF-activated PBL, the cells were analyzed by two-color flow cytometry. TCGF preferentially expanded CD8+CD11− cells and decreased the growth of CD8+CD11+ cells in both normal healthy control subjects and gastric cancer (resectable and nonresectable) patients. Dominantly expressed CD8+CD11− cells on TCGF-activated PBL in patients — especially those with nonresectable gastric carcinoma — showed strong LAS cell activity, irrespective of the presence of killer cell activities of CD8+CD11− cells in TCGF-activated PBL from normal healthy control subjects. The results suggested the generation of CD8+CD11− LAS cells from cancer patients, and revealed that CD8+CD11− T-cells contained killer and/or suppressor cell function. In addition, it was found that the TCGF-activated PBL from gastric cancer patients were associated with an increased proportion of CD4+Leu8+, HLA-DR+CD8+ and HLA-DR+CD25+ cells.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N52bd49425afa43868fbd2e2a68b2e8a1
32 N7d4fc183b1d542c4b6ce90884192f5ca
33 sg:journal.1096240
34 schema:keywords Daudi cells
35 HLA
36 LAK cell activity
37 LAK cells
38 T cells
39 TCGF
40 activity
41 addition
42 assays
43 blood lymphocytes
44 cancer patients
45 carcinoma
46 cell activity
47 cell function
48 cell-mediated cytotoxicity
49 cells
50 characterization
51 control subjects
52 cultivation
53 cytometry
54 cytotoxicity
55 days
56 depression
57 effector cells
58 factors
59 flow cytometry
60 function
61 gastric cancer patients
62 gastric carcinoma
63 generation
64 growth
65 h 51Cr-release assay
66 healthy control subjects
67 inhibition
68 interleukin-2
69 killer
70 killer cell activity
71 killer cells
72 low cytotoxicity
73 lymphocytes
74 lymphokine-activated killer cells
75 lymphokines
76 mechanism
77 mechanisms of depression
78 nonresectable carcinoma
79 normal healthy control subjects
80 patients
81 peripheral blood lymphocytes
82 phenotypic characterization
83 presence
84 proportion
85 reactivity
86 recombinant interleukin-2
87 resectable carcinoma
88 resistant Daudi cells
89 results
90 subjects
91 suppression
92 suppressor cell activity
93 suppressor cell function
94 suppressor cells
95 target tumor cells
96 tumor cells
97 two-color flow cytometry
98 schema:name Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma
99 schema:pagination 218-224
100 schema:productId N998b1395d37947acad6df6f86c62a56e
101 Nd602222fce824aff9185a21b7009cd18
102 Ne7998c93f27040dd9b290fea7abfd5b5
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051413525
104 https://doi.org/10.1007/bf00204992
105 schema:sdDatePublished 2022-09-02T15:46
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher N523771b96fed492f8bd95ec9d3830e6f
108 schema:url https://doi.org/10.1007/bf00204992
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N0c368e914fb245bfad41f734d8e876ee rdf:first sg:person.0657656236.00
113 rdf:rest N4d3d931caae644e68e5c8b3c0c276583
114 N0f6362dfda0e4b19add6c77345db2b28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Aged
116 rdf:type schema:DefinedTerm
117 N110aec6383e04355aa094f0f7f6feca6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Recombinant Proteins
119 rdf:type schema:DefinedTerm
120 N230effeb10c348c7984eacfd41feebeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Killer Cells, Natural
122 rdf:type schema:DefinedTerm
123 N3535a43dd6454d24b55ed3f540e3ad6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cell Separation
125 rdf:type schema:DefinedTerm
126 N3fb54882631c4bd6959f764d6a3c0cad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name T-Lymphocytes, Regulatory
128 rdf:type schema:DefinedTerm
129 N4d3d931caae644e68e5c8b3c0c276583 rdf:first sg:person.01234530531.38
130 rdf:rest N9bc526be44ac42ff9a4a70ad32e1e6c7
131 N523771b96fed492f8bd95ec9d3830e6f schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N52bd49425afa43868fbd2e2a68b2e8a1 schema:issueNumber 3
134 rdf:type schema:PublicationIssue
135 N5541cc9268df4fe59039609e041fe37f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cytotoxicity, Immunologic
137 rdf:type schema:DefinedTerm
138 N569d59315dc246af9bd89440f32e77c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Antigens, Differentiation
140 rdf:type schema:DefinedTerm
141 N640cf1e41c414b709e2d81bec57c0613 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Middle Aged
143 rdf:type schema:DefinedTerm
144 N7d4fc183b1d542c4b6ce90884192f5ca schema:volumeNumber 28
145 rdf:type schema:PublicationVolume
146 N8138b1a7658047f98d25a1b311d4e553 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Interleukin-2
148 rdf:type schema:DefinedTerm
149 N998b1395d37947acad6df6f86c62a56e schema:name doi
150 schema:value 10.1007/bf00204992
151 rdf:type schema:PropertyValue
152 N9bc526be44ac42ff9a4a70ad32e1e6c7 rdf:first sg:person.0661061456.78
153 rdf:rest rdf:nil
154 Na586cc16230e4548addcc863b50f1b8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Phenotype
156 rdf:type schema:DefinedTerm
157 Nc08b12f2f94240c4b89702252c85b924 rdf:first sg:person.01073271343.46
158 rdf:rest N0c368e914fb245bfad41f734d8e876ee
159 Nc183850d52e840c1ad92b4e9165ea73c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name HLA-DR Antigens
161 rdf:type schema:DefinedTerm
162 Nc3117c25cec44365ad0da784855e10f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Stomach Neoplasms
164 rdf:type schema:DefinedTerm
165 Nce75938bc60a4c61ae5d7f06b342de40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Adult
167 rdf:type schema:DefinedTerm
168 Nd602222fce824aff9185a21b7009cd18 schema:name pubmed_id
169 schema:value 2522349
170 rdf:type schema:PropertyValue
171 Nd75c7c09b7e6452ea6d080fb1089c4d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Humans
173 rdf:type schema:DefinedTerm
174 Ne7998c93f27040dd9b290fea7abfd5b5 schema:name dimensions_id
175 schema:value pub.1051413525
176 rdf:type schema:PropertyValue
177 Nf9c6d361798d4d208d8a18687e2ce2e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Lymphocyte Activation
179 rdf:type schema:DefinedTerm
180 Nfbaf817644cf438b903bf5ecbbbe72e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Carcinoma
182 rdf:type schema:DefinedTerm
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
187 schema:name Immunology
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
190 schema:name Oncology and Carcinogenesis
191 rdf:type schema:DefinedTerm
192 sg:journal.1096240 schema:issn 0340-7004
193 1432-0851
194 schema:name Cancer Immunology, Immunotherapy
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01073271343.46 schema:affiliation grid-institutes:grid.20515.33
198 schema:familyName Ebihara
199 schema:givenName Tsugio
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073271343.46
201 rdf:type schema:Person
202 sg:person.01234530531.38 schema:affiliation grid-institutes:grid.20515.33
203 schema:familyName Fukao
204 schema:givenName Katashi
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234530531.38
206 rdf:type schema:Person
207 sg:person.0657656236.00 schema:affiliation grid-institutes:grid.20515.33
208 schema:familyName Koyama
209 schema:givenName Shohei
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00
211 rdf:type schema:Person
212 sg:person.0661061456.78 schema:affiliation grid-institutes:grid.20515.33
213 schema:familyName Osuga
214 schema:givenName Toshiaki
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661061456.78
216 rdf:type schema:Person
217 sg:pub.10.1007/bf00917143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003089650
218 https://doi.org/10.1007/bf00917143
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/bf02468883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038549596
221 https://doi.org/10.1007/bf02468883
222 rdf:type schema:CreativeWork
223 sg:pub.10.1038/280685a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006685440
224 https://doi.org/10.1038/280685a0
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/291335a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036146781
227 https://doi.org/10.1038/291335a0
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/311565a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015470890
230 https://doi.org/10.1038/311565a0
231 rdf:type schema:CreativeWork
232 grid-institutes:grid.20515.33 schema:alternateName Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan
233 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, 305, Tsukuba City, Japan
234 schema:name Department of Internal Medicine, University of Tsukuba, 305, Tsukuba City, Japan
235 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, 305, Tsukuba City, Japan
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...